Literature DB >> 22148755

Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Zachary B Hill1, B Gayani K Perera, Simeon S Andrews, Dustin J Maly.   

Abstract

The identification of potent and selective modulators of protein kinase function remains a challenge, and new strategies are needed for generating these useful ligands. Here, we describe the generation of bivalent inhibitors of three unrelated protein kinases: the CAMK family kinase Pim1, the mitogen-activated protein kinase (MAPK) p38α, and the receptor tyrosine kinase (RTK) epidermal growth factor receptor (EGFR). These bivalent inhibitors consist of an ATP-competitive inhibitor that is covalently tethered to an engineered form of the self-labeling protein O(6)-alkylguanine-DNA alkyltransferase (SNAP-tag). In each example, SNAP-tag is fused to a peptide ligand that binds to a signaling interaction site of the kinase being targeted. These interactions increase the overall selectivity and potency of the bivalent inhibitors that were generated. The ability to exploit disparate binding sites in diverse kinases points to the generality of the method described. Finally, we demonstrate that ATP-competitive inhibitors that are conjugated to the bio-orthogonal tag O(4)-benzyl-2-chloro-6-aminopyrimidine (CLP) are cell-permeable. The selective labeling of SNAP-tag with CLP conjugates allows the rapid assembly of bivalent inhibitors in living cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22148755      PMCID: PMC3306478          DOI: 10.1021/cb200387g

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  49 in total

1.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  Selectivity of docking sites in MAPK kinases.

Authors:  A Jane Bardwell; Erlynn Frankson; Lee Bardwell
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

3.  Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitor.

Authors:  John L Stebbins; Surya K De; Petra Pavlickova; Vida Chen; Thomas Machleidt; Li-Hsing Chen; Christian Kuntzen; Shinichi Kitada; Michael Karin; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2011-08-23       Impact factor: 7.446

4.  Measuring in vivo protein half-life.

Authors:  Karolina Bojkowska; Francesca Santoni de Sio; Isabelle Barde; Sandra Offner; Sonia Verp; Christian Heinis; Kai Johnsson; Didier Trono
Journal:  Chem Biol       Date:  2011-06-24

Review 5.  Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.

Authors:  Kurt J Cox; Carolyn D Shomin; Indraneel Ghosh
Journal:  Future Med Chem       Date:  2011-01       Impact factor: 3.808

6.  Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling.

Authors:  Duangkhae Srikun; Aaron E Albers; Christine I Nam; Anthony T Iavarone; Christopher J Chang
Journal:  J Am Chem Soc       Date:  2010-03-31       Impact factor: 15.419

7.  Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.

Authors:  Zachary B Hill; B Gayani K Perera; Dustin J Maly
Journal:  Mol Biosyst       Date:  2010-11-09

8.  Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Lisa S Chen; Sanjeev Redkar; David Bearss; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2009-09-04       Impact factor: 22.113

9.  Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): optimization and selectivity profiling.

Authors:  Carolyn D Shomin; Scott C Meyer; Indraneel Ghosh
Journal:  Bioorg Med Chem       Date:  2009-07-26       Impact factor: 3.641

Review 10.  Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.

Authors:  Nilesh Shah; Brendan Pang; Khay-Guan Yeoh; Shannon Thorn; Chien Shing Chen; Michael B Lilly; Manuel Salto-Tellez
Journal:  Eur J Cancer       Date:  2008-08-18       Impact factor: 9.162

View more
  11 in total

1.  The ins and outs of selective kinase inhibitor development.

Authors:  Susanne Müller; Apirat Chaikuad; Nathanael S Gray; Stefan Knapp
Journal:  Nat Chem Biol       Date:  2015-11       Impact factor: 15.040

Review 2.  Ten things you should know about protein kinases: IUPHAR Review 14.

Authors:  Doriano Fabbro; Sandra W Cowan-Jacob; Henrik Moebitz
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

Review 3.  Bivalent inhibitors of protein kinases.

Authors:  Carrie M Gower; Matthew E K Chang; Dustin J Maly
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-25       Impact factor: 8.250

4.  Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.

Authors:  Melody D Fulton; Laura E Hanold; Zheng Ruan; Sneha Patel; Aaron M Beedle; Natarajan Kannan; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2017-09-05       Impact factor: 3.641

5.  Label transfer reagents to probe p38 MAPK binding partners.

Authors:  Simeon S Andrews; Zachary B Hill; B Gayani K Perera; Dustin J Maly
Journal:  Chembiochem       Date:  2013-01-14       Impact factor: 3.164

6.  Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity.

Authors:  Carrie M Gower; Jason R Thomas; Edmund Harrington; Jason Murphy; Matthew E K Chang; Ivan Cornella-Taracido; Rishi K Jain; Markus Schirle; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2015-11-06       Impact factor: 5.100

7.  A peptide photoaffinity probe specific for the active conformation of the Abl tyrosine kinase.

Authors:  Yang Deng; Brian A Couch; Anthony J Koleske; Benjamin E Turk
Journal:  Chembiochem       Date:  2012-10-18       Impact factor: 3.164

8.  Chemical Modification of Phage-Displayed Helix-Loop-Helix Peptides to Construct Kinase-Focused Libraries.

Authors:  Daisuke Fujiwara; Kousuke Mihara; Ryo Takayama; Yusuke Nakamura; Mitsuhiro Ueda; Takeshi Tsumuraya; Ikuo Fujii
Journal:  Chembiochem       Date:  2021-10-19       Impact factor: 3.461

9.  Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.

Authors:  Stephen E Leonard; A C Register; Ratika Krishnamurty; Gabriel J Brighty; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2014-07-02       Impact factor: 5.100

10.  Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors.

Authors:  Margaret L Wong; Jason Murphy; Edmund Harrington; Carrie M Gower; Rishi K Jain; Markus Schirle; Jason R Thomas
Journal:  Proteome Sci       Date:  2017-07-17       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.